Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer [Phase 2]
A randomized Phase II trial evaluating ixabepilone alone versus ixabepilone plus cetuximab as first-line therapy for women with triple-negat…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Trial of RAD001 in Triple Negative Metastatic Breast Cancer [Phase 2]
A Phase 2 trial of RAD001 (everolimus) in triple-negative metastatic breast cancer was terminated, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial [Phase 2]
This document summarizes a Phase 2 prospective trial evaluating salvage chemotherapy with Vinorelbine plus Oxaliplatin for metastatic triple…
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients [Phase 2]
This document notes the completion of a Phase 2 trial of EndoTAG-1 in patients with triple-negative breast cancer. The study sponsor is Medi…
-
CLINICAL_TRIALS research · 2011-12-28Clinical Trial Update: The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC [Phase 3]
This clinical trial update describes a Phase 3 study comparing dose-dense AC-T (doxorubicin/cyclophosphamide followed by paclitaxel) with PC…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-11-16Clinical Trial Update: Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer [Phase 2]
This is a Phase 2 neoadjuvant trial evaluating a paclitaxel plus carboplatin and epirubicin regimen in triple-negative breast cancer. The tr…
-
CLINICAL_TRIALS trial_result · 2011-07-04Clinical Trial Update: Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC [Phase 2]
A Phase 2 trial evaluating gemcitabine and cisplatin as first-line therapy for triple-negative metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer [Phase 2]
Pfizer conducted a Phase 2 trial comparing SU011248 to standard chemotherapy in patients with previously treated triple-negative breast canc…
-
CLINICAL_TRIALS trial_result · 2010-10-07Clinical Trial Update: Efficacy and Safety Study of Neoadjuvant Chemotherapy for Local Advanced Triple Negative Breast Cancer Patients
This clinical trial update discusses the efficacy and safety of neoadjuvant chemotherapy in locally advanced triple-negative breast cancer. …